Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 14Leukemia, Myeloid, Acute 11Leukemia 7Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 3Jacobs syndrome 3Sarcoma 2Purpura, Thrombocytopenic, Idiopathic 2Multiple Myeloma 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Hematologic Neoplasms 2Congenital Abnormalities 2Solid Tumor, Childhood 1Recurrence 1Primary Myelofibrosis 1Pathologic Complete Response 1Osteosarcoma 1Neoplasms, Connective and Soft Tissue 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

romiplostim 1hetrombopag 1eltrombopag 1avatrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chemotherapy-induced Thrombocytopenia × eltrombopag × Clear all
NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡